Somenone told me that this is a new thing that has been found for this drug. I want to know is it true or not
"... FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin, were reported to the Agency between October 2006 and February 2009. It is recommended that healthcare professionals monitor patients carefully for the development of pancreatitis after initiation or dose increases of sitagliptin or sitagliptin/metformin. Sitagliptin has not been studied in patients with a history of pancreatitis. Therefore, it is not known whether these patients are at an increased risk for developing pancreatitis and the medication should be used with caution and with appropriate monitoring in patients with a history of pancreatitis. Considerations for healthcare professionals, information for patients, and a Data Summary are provided."
The key point is that there may be an increased risk in developing pancreatitis (not pancreatic cancer) and that the drugs should be used with caution if there is a patient history of pancreatitis.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 26 Oct 2010 • 3 answers
Posted 11 May 2011 • 1 answer
Posted 27 Mar 2012 • 0 answers
Posted 31 Oct 2012 • 2 answers
Posted 26 Dec 2014 • 2 answers